Clinical Trial Update: VLA1553-403 Pregnancy Surveillance Study

View source ↗

Summary

Pregnancy surveillance study VLA1553-403 for the chikungunya vaccine VLA1553 is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chikungunya Virus Infection

Drugs mentioned

• VLA1553

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Chikungunya Virus Infection | Status: NOT_YET_RECRUITING